Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 364

1.

The ubiquitin-editing enzyme A20 controls NK cell homeostasis through regulation of mTOR activity and TNF.

Vetters J, van Helden MJ, Wahlen S, Tavernier SJ, Martens A, Fayazpour F, Vergote K, Vanheerswynghels M, Deswarte K, Van Moorleghem J, De Prijck S, Takahashi N, Vandenabeele P, Boon L, van Loo G, Vivier E, Lambrecht BN, Janssens S.

J Exp Med. 2019 Jul 11. pii: jem.20182164. doi: 10.1084/jem.20182164. [Epub ahead of print]

PMID:
31296735
2.

Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions.

Dou Y, Xing J, Kong G, Wang G, Lou X, Xiao X, Vivier E, Li XC, Zhang Z.

J Immunol. 2019 Jul 3. pii: ji1900171. doi: 10.4049/jimmunol.1900171. [Epub ahead of print]

PMID:
31270148
3.

Inherited IL-18BP deficiency in human fulminant viral hepatitis.

Belkaya S, Michailidis E, Korol CB, Kabbani M, Cobat A, Bastard P, Lee YS, Hernandez N, Drutman S, de Jong YP, Vivier E, Bruneau J, Béziat V, Boisson B, Lorenzo-Diaz L, Boucherit S, Sebagh M, Jacquemin E, Emile JF, Abel L, Rice CM, Jouanguy E, Casanova JL.

J Exp Med. 2019 Jun 18. pii: jem.20190669. doi: 10.1084/jem.20190669. [Epub ahead of print]

PMID:
31213488
4.

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.

Gauthier L, Morel A, Anceriz N, Rossi B, Blanchard-Alvarez A, Grondin G, Trichard S, Cesari C, Sapet M, Bosco F, Rispaud-Blanc H, Guillot F, Cornen S, Roussel A, Amigues B, Habif G, Caraguel F, Arrufat S, Remark R, Romagné F, Morel Y, Narni-Mancinelli E, Vivier E.

Cell. 2019 Jun 13;177(7):1701-1713.e16. doi: 10.1016/j.cell.2019.04.041. Epub 2019 May 30.

PMID:
31155232
5.

The Innate Part of the Adaptive Immune System.

Hillion S, Arleevskaya MI, Blanco P, Bordron A, Brooks WH, Cesbron JY, Kaveri S, Vivier E, Renaudineau Y.

Clin Rev Allergy Immunol. 2019 Jun 1. doi: 10.1007/s12016-019-08740-1. [Epub ahead of print] Review.

PMID:
31154567
6.

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies.

Perrot I, Michaud HA, Giraudon-Paoli M, Augier S, Docquier A, Gros L, Courtois R, Déjou C, Jecko D, Becquart O, Rispaud-Blanc H, Gauthier L, Rossi B, Chanteux S, Gourdin N, Amigues B, Roussel A, Bensussan A, Eliaou JF, Bastid J, Romagné F, Morel Y, Narni-Mancinelli E, Vivier E, Paturel C, Bonnefoy N.

Cell Rep. 2019 May 21;27(8):2411-2425.e9. doi: 10.1016/j.celrep.2019.04.091.

7.

Atrophy of Diaphragm and Pectoral Muscles in Critically Ill Patients.

Vivier E, Roussey A, Doroszewski F, Rosselli S, Pommier C, Carteaux G, Mekontso Dessap A.

Anesthesiology. 2019 May 14. doi: 10.1097/ALN.0000000000002737. [Epub ahead of print]

PMID:
31094757
8.

Helper-like innate lymphoid cells and cancer immunotherapy.

Crinier A, Vivier E, Bléry M.

Semin Immunol. 2019 May 6. pii: S1044-5323(18)30081-2. doi: 10.1016/j.smim.2019.04.002. [Epub ahead of print] Review.

9.

Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2.

Cherfils-Vicini J, Iltis C, Cervera L, Pisano S, Croce O, Sadouni N, Győrffy B, Collet R, Renault VM, Rey-Millet M, Leonetti C, Zizza P, Allain F, Ghiringhelli F, Soubeiran N, Shkreli M, Vivier E, Biroccio A, Gilson E.

EMBO J. 2019 Jun 3;38(11). pii: e100012. doi: 10.15252/embj.2018100012. Epub 2019 Apr 18.

PMID:
31000523
10.

Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2.

Zhou L, Chu C, Teng F, Bessman NJ, Goc J, Santosa EK, Putzel GG, Kabata H, Kelsen JR, Baldassano RN, Shah MA, Sockolow RE, Vivier E, Eberl G, Smith KA, Sonnenberg GF.

Nature. 2019 Apr;568(7752):405-409. doi: 10.1038/s41586-019-1082-x. Epub 2019 Apr 3.

PMID:
30944470
11.

Shp-2 is critical for ERK and metabolic engagement downstream of IL-15 receptor in NK cells.

Niogret C, Miah SMS, Rota G, Fonta NP, Wang H, Held W, Birchmeier W, Sexl V, Yang W, Vivier E, Ho PC, Brossay L, Guarda G.

Nat Commun. 2019 Mar 29;10(1):1444. doi: 10.1038/s41467-019-09431-3.

12.

Targeting natural killer cells in solid tumors.

Habif G, Crinier A, André P, Vivier E, Narni-Mancinelli E.

Cell Mol Immunol. 2019 May;16(5):415-422. doi: 10.1038/s41423-019-0224-2. Epub 2019 Mar 25. Review.

PMID:
30911118
13.

Inability of Diaphragm Ultrasound to Predict Extubation Failure: A Multicenter Study.

Vivier E, Muller M, Putegnat JB, Steyer J, Barrau S, Boissier F, Bourdin G, Mekontso-Dessap A, Levrat A, Pommier C, Thille AW.

Chest. 2019 Jun;155(6):1131-1139. doi: 10.1016/j.chest.2019.03.004. Epub 2019 Mar 23.

PMID:
30910636
14.

Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial.

Frat JP, Ricard JD, Quenot JP, Pichon N, Demoule A, Forel JM, Mira JP, Coudroy R, Berquier G, Voisin B, Colin G, Pons B, Danin PE, Devaquet J, Prat G, Clere-Jehl R, Petitpas F, Vivier E, Razazi K, Nay MA, Souday V, Dellamonica J, Argaud L, Ehrmann S, Gibelin A, Girault C, Andreu P, Vignon P, Dangers L, Ragot S, Thille AW; FLORALI-2 study group; REVA network.

Lancet Respir Med. 2019 Apr;7(4):303-312. doi: 10.1016/S2213-2600(19)30048-7. Epub 2019 Mar 18.

PMID:
30898520
15.

Chemotherapy and tumor immunity.

Cornen S, Vivier E.

Science. 2018 Dec 21;362(6421):1355-1356. doi: 10.1126/science.aav7871. No abstract available.

PMID:
30573614
16.

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.

André P, Denis C, Soulas C, Bourbon-Caillet C, Lopez J, Arnoux T, Bléry M, Bonnafous C, Gauthier L, Morel A, Rossi B, Remark R, Breso V, Bonnet E, Habif G, Guia S, Lalanne AI, Hoffmann C, Lantz O, Fayette J, Boyer-Chammard A, Zerbib R, Dodion P, Ghadially H, Jure-Kunkel M, Morel Y, Herbst R, Narni-Mancinelli E, Cohen RB, Vivier E.

Cell. 2018 Dec 13;175(7):1731-1743.e13. doi: 10.1016/j.cell.2018.10.014. Epub 2018 Nov 29.

17.

High-Dimensional Single-Cell Analysis Identifies Organ-Specific Signatures and Conserved NK Cell Subsets in Humans and Mice.

Crinier A, Milpied P, Escalière B, Piperoglou C, Galluso J, Balsamo A, Spinelli L, Cervera-Marzal I, Ebbo M, Girard-Madoux M, Jaeger S, Bollon E, Hamed S, Hardwigsen J, Ugolini S, Vély F, Narni-Mancinelli E, Vivier E.

Immunity. 2018 Nov 20;49(5):971-986.e5. doi: 10.1016/j.immuni.2018.09.009. Epub 2018 Nov 6.

18.

Author Correction: Natural killer cells and other innate lymphoid cells in cancer.

Chiossone L, Dumas PY, Vienne M, Vivier E.

Nat Rev Immunol. 2018 Nov;18(11):726. doi: 10.1038/s41577-018-0077-4.

PMID:
30315207
19.

Neuroendocrine regulation of innate lymphoid cells.

Quatrini L, Vivier E, Ugolini S.

Immunol Rev. 2018 Nov;286(1):120-136. doi: 10.1111/imr.12707. Review.

20.

A point mutation in the Ncr1 signal peptide impairs the development of innate lymphoid cell subsets.

Almeida FF, Tognarelli S, Marçais A, Kueh AJ, Friede ME, Liao Y, Willis SN, Luong K, Faure F, Mercier FE, Galluso J, Firth M, Narni-Mancinelli E, Rais B, Scadden DT, Spallotta F, Weil S, Giannattasio A, Kalensee F, Zöller T, Huntington ND, Schleicher U, Chiocchetti AG, Ugolini S, Herold MJ, Shi W, Koch J, Steinle A, Vivier E, Walzer T, Belz GT, Ullrich E.

Oncoimmunology. 2018 Aug 15;7(10):e1475875. doi: 10.1080/2162402X.2018.1475875. eCollection 2018.

21.

Natural killer cells and other innate lymphoid cells in cancer.

Chiossone L, Dumas PY, Vienne M, Vivier E.

Nat Rev Immunol. 2018 Nov;18(11):671-688. doi: 10.1038/s41577-018-0061-z. Review. Erratum in: Nat Rev Immunol. 2018 Oct 12;:.

PMID:
30209347
22.

High-flow nasal cannula oxygen therapy alone or with non-invasive ventilation during the weaning period after extubation in ICU: the prospective randomised controlled HIGH-WEAN protocol.

Thille AW, Muller G, Gacouin A, Coudroy R, Demoule A, Sonneville R, Beloncle F, Girault C, Dangers L, Lautrette A, Cabasson S, Rouzé A, Vivier E, Le Meur A, Ricard JD, Razazi K, Barberet G, Lebert C, Ehrmann S, Picard W, Bourenne J, Pradel G, Bailly P, Terzi N, Buscot M, Lacave G, Danin PE, Nanadoumgar H, Gibelin A, Zanre L, Deye N, Ragot S, Frat JP; REVA research network.

BMJ Open. 2018 Sep 5;8(9):e023772. doi: 10.1136/bmjopen-2018-023772.

23.

Innate Lymphoid Cells: 10 Years On.

Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Spits H.

Cell. 2018 Aug 23;174(5):1054-1066. doi: 10.1016/j.cell.2018.07.017. Review.

PMID:
30142344
24.

Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells.

Quatrini L, Wieduwild E, Escaliere B, Filtjens J, Chasson L, Laprie C, Vivier E, Ugolini S.

Nat Immunol. 2018 Sep;19(9):954-962. doi: 10.1038/s41590-018-0185-0. Epub 2018 Aug 20.

25.

Reply to 'Comment on: Evidence of innate lymphoid cell redundancy in humans'.

Vivier E, Vély F, Fischer A.

Nat Immunol. 2018 Aug;19(8):789-790. doi: 10.1038/s41590-018-0165-4. No abstract available.

PMID:
30026478
26.

The transcription factor Rfx7 limits metabolism of NK cells and promotes their maintenance and immunity.

Castro W, Chelbi ST, Niogret C, Ramon-Barros C, Welten SPM, Osterheld K, Wang H, Rota G, Morgado L, Vivier E, Raeber ME, Boyman O, Delorenzi M, Barras D, Ho PC, Oxenius A, Guarda G.

Nat Immunol. 2018 Aug;19(8):809-820. doi: 10.1038/s41590-018-0144-9. Epub 2018 Jul 2.

27.

Author Correction: T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation.

Kwong B, Rua R, Gao Y, Flickinger J Jr, Wang Y, Kruhlak MJ, Zhu J, Vivier E, McGavern DB, Lazarevic V.

Nat Immunol. 2018 Aug;19(8):898. doi: 10.1038/s41590-018-0139-6.

PMID:
29959442
28.

Activating and inhibitory receptors expressed on innate lymphoid cells.

Guia S, Fenis A, Vivier E, Narni-Mancinelli E.

Semin Immunopathol. 2018 Jul;40(4):331-341. doi: 10.1007/s00281-018-0685-x. Epub 2018 May 22. Review.

PMID:
29789862
29.

ILC2 memory: Recollection of previous activation.

Martinez-Gonzalez I, Ghaedi M, Steer CA, Mathä L, Vivier E, Takei F.

Immunol Rev. 2018 May;283(1):41-53. doi: 10.1111/imr.12643. Review.

PMID:
29664572
30.

Crk Adaptor Proteins Regulate NK Cell Expansion and Differentiation during Mouse Cytomegalovirus Infection.

Nabekura T, Chen Z, Schroeder C, Park T, Vivier E, Lanier LL, Liu D.

J Immunol. 2018 May 15;200(10):3420-3428. doi: 10.4049/jimmunol.1701639. Epub 2018 Apr 4.

31.

Shp-2 Is Dispensable for Establishing T Cell Exhaustion and for PD-1 Signaling In Vivo.

Rota G, Niogret C, Dang AT, Barros CR, Fonta NP, Alfei F, Morgado L, Zehn D, Birchmeier W, Vivier E, Guarda G.

Cell Rep. 2018 Apr 3;23(1):39-49. doi: 10.1016/j.celrep.2018.03.026.

32.

NKG2D-MICA Interaction: A Paradigm Shift in Innate Recognition.

Bléry M, Vivier E.

J Immunol. 2018 Apr 1;200(7):2229-2230. doi: 10.4049/jimmunol.1800176. No abstract available.

33.

The immunological functions of the Appendix: An example of redundancy?

Girard-Madoux MJH, Gomez de Agüero M, Ganal-Vonarburg SC, Mooser C, Belz GT, Macpherson AJ, Vivier E.

Semin Immunol. 2018 Apr;36:31-44. doi: 10.1016/j.smim.2018.02.005. Epub 2018 Mar 2. Review.

PMID:
29503124
34.

Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection.

Ng SS, Souza-Fonseca-Guimaraes F, Rivera FL, Amante FH, Kumar R, Gao Y, Sheel M, Beattie L, Montes de Oca M, Guillerey C, Edwards CL, Faleiro RJ, Frame T, Bunn PT, Vivier E, Godfrey DI, Pellicci DG, Lopez JA, Andrews KT, Huntington ND, Smyth MJ, McCarthy J, Engwerda CR.

Clin Transl Immunology. 2018 Jan 12;7(1):e1003. doi: 10.1002/cti2.1003. eCollection 2018.

35.

Role of NKp46+ natural killer cells in house dust mite-driven asthma.

Haspeslagh E, van Helden MJ, Deswarte K, De Prijck S, van Moorleghem J, Boon L, Hammad H, Vivier E, Lambrecht BN.

EMBO Mol Med. 2018 Apr;10(4). pii: e8657. doi: 10.15252/emmm.201708657.

36.

A hospital-wide intervention replacing ceftriaxone with cefotaxime to reduce rate of healthcare-associated infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the intensive care unit.

Tan BK, Vivier E, Bouziad KA, Zahar JR, Pommier C, Parmeland L, Pariset C, Misslin P, Haond C, Poirié P, Temime L, Hocine MN.

Intensive Care Med. 2018 May;44(5):672-673. doi: 10.1007/s00134-018-5079-y. Epub 2018 Feb 2. No abstract available.

PMID:
29396655
37.

Cardiac function during weaning failure: the role of diastolic dysfunction.

Roche-Campo F, Bedet A, Vivier E, Brochard L, Mekontso Dessap A.

Ann Intensive Care. 2018 Jan 9;8(1):2. doi: 10.1186/s13613-017-0348-4.

38.

[New frontiers in the fight against cancer].

Chiossone L, Vivier E.

Biol Aujourdhui. 2018;212(3-4):61-67. doi: 10.1051/jbio/2019011. Epub 2019 Apr 11. French.

PMID:
30973133
39.

A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment.

Young A, Ngiow SF, Gao Y, Patch AM, Barkauskas DS, Messaoudene M, Lin G, Coudert JD, Stannard KA, Zitvogel L, Degli-Esposti MA, Vivier E, Waddell N, Linden J, Huntington ND, Souza-Fonseca-Guimaraes F, Smyth MJ.

Cancer Res. 2018 Feb 15;78(4):1003-1016. doi: 10.1158/0008-5472.CAN-17-2826. Epub 2017 Dec 11.

40.

ITIMs: episode 1 of the inhibitory saga.

Vivier E.

Nat Rev Immunol. 2018 Jan;18(1):4. doi: 10.1038/nri.2017.134. Epub 2017 Nov 27. No abstract available.

PMID:
29176731
41.

Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis.

Krzywinska E, Kantari-Mimoun C, Kerdiles Y, Sobecki M, Isagawa T, Gotthardt D, Castells M, Haubold J, Millien C, Viel T, Tavitian B, Takeda N, Fandrey J, Vivier E, Sexl V, Stockmann C.

Nat Commun. 2017 Nov 17;8(1):1597. doi: 10.1038/s41467-017-01599-w.

42.

Host resistance to endotoxic shock requires the neuroendocrine regulation of group 1 innate lymphoid cells.

Quatrini L, Wieduwild E, Guia S, Bernat C, Glaichenhaus N, Vivier E, Ugolini S.

J Exp Med. 2017 Dec 4;214(12):3531-3541. doi: 10.1084/jem.20171048. Epub 2017 Nov 15.

43.

Editorial: NK Cell Subsets in Health and Disease: New Developments.

Marcenaro E, Notarangelo LD, Orange JS, Vivier E.

Front Immunol. 2017 Oct 18;8:1363. doi: 10.3389/fimmu.2017.01363. eCollection 2017. No abstract available.

44.

Genetic Depletion or Hyperresponsiveness of Natural Killer Cells Do Not Affect Atherosclerosis Development.

Nour-Eldine W, Joffre J, Zibara K, Esposito B, Giraud A, Zeboudj L, Vilar J, Terada M, Bruneval P, Vivier E, Ait-Oufella H, Mallat Z, Ugolini S, Tedgui A.

Circ Res. 2018 Jan 5;122(1):47-57. doi: 10.1161/CIRCRESAHA.117.311743. Epub 2017 Oct 18.

PMID:
29046274
45.

Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more.

Chiossone L, Vienne M, Kerdiles YM, Vivier E.

Semin Immunol. 2017 Jun;31:55-63. doi: 10.1016/j.smim.2017.08.003. Epub 2017 Sep 22. Review.

PMID:
28943093
46.

Determinants of diaphragm thickening fraction during mechanical ventilation: an ancillary study of a randomised trial.

Vivier E, Roche-Campo F, Brochard L, Mekontso Dessap A.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700783. doi: 10.1183/13993003.00783-2017. Print 2017 Sep. No abstract available.

47.

High mTOR activity is a hallmark of reactive natural killer cells and amplifies early signaling through activating receptors.

Marçais A, Marotel M, Degouve S, Koenig A, Fauteux-Daniel S, Drouillard A, Schlums H, Viel S, Besson L, Allatif O, Bléry M, Vivier E, Bryceson Y, Thaunat O, Walzer T.

Elife. 2017 Sep 6;6. pii: e26423. doi: 10.7554/eLife.26423.

48.

Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells.

Kerdiles YM, Almeida FF, Thompson T, Chopin M, Vienne M, Bruhns P, Huntington ND, Raulet DH, Nutt SL, Belz GT, Vivier E.

Immunity. 2017 Aug 15;47(2):199-200. doi: 10.1016/j.immuni.2017.07.026. No abstract available.

49.

T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation.

Kwong B, Rua R, Gao Y, Flickinger J Jr, Wang Y, Kruhlak MJ, Zhu J, Vivier E, McGavern DB, Lazarevic V.

Nat Immunol. 2017 Oct;18(10):1117-1127. doi: 10.1038/ni.3816. Epub 2017 Aug 14. Erratum in: Nat Immunol. 2018 Aug;19(8):898.

50.

Innate lymphoid cells: major players in inflammatory diseases.

Ebbo M, Crinier A, Vély F, Vivier E.

Nat Rev Immunol. 2017 Nov;17(11):665-678. doi: 10.1038/nri.2017.86. Epub 2017 Aug 14. Review.

PMID:
28804130

Supplemental Content

Loading ...
Support Center